AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $39,357,000 | -32.9% | 1,401,119 | -9.5% | 0.01% | -28.6% |
| Q2 2019 | $58,621,000 | -43.1% | 1,548,363 | -41.3% | 0.01% | -41.7% |
| Q1 2019 | $103,005,000 | +53.3% | 2,639,810 | -16.2% | 0.01% | +33.3% |
| Q4 2018 | $67,198,000 | -56.4% | 3,151,884 | -19.1% | 0.01% | -47.1% |
| Q3 2018 | $154,258,000 | -6.8% | 3,896,391 | -10.1% | 0.02% | -10.5% |
| Q2 2018 | $165,520,000 | +9.4% | 4,331,844 | -14.0% | 0.02% | +5.6% |
| Q1 2018 | $151,303,000 | +9.7% | 5,035,067 | +14.1% | 0.02% | +12.5% |
| Q4 2017 | $137,864,000 | +50.4% | 4,411,633 | +34.8% | 0.02% | +45.5% |
| Q3 2017 | $91,665,000 | +1392.7% | 3,272,598 | +919.5% | 0.01% | +1000.0% |
| Q2 2017 | $6,141,000 | +8.9% | 321,000 | -3.0% | 0.00% | 0.0% |
| Q1 2017 | $5,640,000 | -11.8% | 331,000 | -5.4% | 0.00% | 0.0% |
| Q4 2016 | $6,395,000 | +2.6% | 350,000 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $6,234,000 | – | 350,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 1,204,615 | $37,644,219,000 | 39.61% |
| Casdin Capital, LLC | 400,000 | $12,500,000 | 3.04% |
| Opaleye Management Inc. | 210,000 | $6,652,000 | 2.13% |
| Orbimed Advisors | 4,129,638 | $129,051,000 | 1.63% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,190,516 | $37,204,000 | 1.46% |
| Redmile Group, LLC | 929,326 | $29,041,000 | 1.26% |
| Cormorant Asset Management, LP | 337,876 | $10,559,000 | 1.10% |
| Perceptive Advisors | 781,309 | $24,416,000 | 0.81% |
| Rock Springs Capital Management LP | 525,000 | $16,406,000 | 0.74% |
| Virtus ETF Advisers LLC | 11,898 | $372,000 | 0.47% |